STEM Times Arkansas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM Times Arkansas.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on March 30, 2026

Mar. 30, 2026

AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program

GlobeNewswire

Mar. 30, 2026

Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million

GlobeNewswire

Mar. 30, 2026

APA Solar Racking Announces Opening of New Headquarters in Ohio

GlobeNewswire

Mar. 30, 2026

RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire

Mar. 30, 2026

QCI Deploys Chatalytics™ at Batavia Downs Gaming & Hotel, Bringing Conversational Intelligence to Gaming

GlobeNewswire

Mar. 30, 2026

Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones

GlobeNewswire

Mar. 30, 2026

Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial Results

GlobeNewswire

Mar. 30, 2026

Aktis Oncology Announces FDA Clearance of Investigational New Drug Applications for AKY-2519 and Provides Business Updates and Full Year 2025 Financial Results

GlobeNewswire

Mar. 30, 2026

Palisade Bio Reports Positive Topline Data from Phase 1b Clinical Study of PALI-2108 in Fibrostenotic Crohn’s Disease

GlobeNewswire

Mar. 30, 2026

Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs

GlobeNewswire

Mar. 30, 2026

INmune Bio Inc. Announces 2025 Results and Provides Business Update

GlobeNewswire

Mar. 30, 2026

Uplight Announces Leadership Transition Following Strategic Investment to Accelerate Customer-Driven Grid Reliability

GlobeNewswire

Mar. 30, 2026

IGEL Recognizes Nutanix, Omnissa, NVIDIA, HP and Imprivata as 2026 IGEL Ready Partners of the Year

GlobeNewswire

Mar. 30, 2026

Acoramidis Significantly Reduces the Risk of All-Cause and Cardiovascular Mortality in Patients with ATTR-CM through Month 54

GlobeNewswire

Mar. 30, 2026

Xtra Responds to Creator Demand for Extra Camera Choices, Outlines Future Product Strategy for Xtra Muse and Xtra Atto

GlobeNewswire

Mar. 30, 2026

Asure Appoints Tiffany Mortimer as Chief Transformation & People Officer

GlobeNewswire

Mar. 30, 2026

Horizon Market Adds Ordinals, Becoming the Only Marketplace for Every Major Bitcoin NFT Protocol

GlobeNewswire

Mar. 30, 2026

Red Cat Closes Acquisition of Apium Swarm Robotics

GlobeNewswire

Mar. 30, 2026

Persona AI Announces Brian Davis as Head of Global Manufacturing

GlobeNewswire

Mar. 30, 2026

BioCleaners Directory Launches Free Nationwide Search Tool for Biohazard Cleanup Services

GlobeNewswire